Clinical Trials
4 trialsNCT01119118 2019-11-21
ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer
University of Wisconsin, Madison
Phase 2 Terminated
NCT01000948 2014-01-08
DAPROCA-1
Aarhus University Hospital
Phase 2 Terminated
NCT00055471 2012-10-31
A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer
AstraZeneca
Phase 2 Completed
NCT01168141 2010-07-23
Window Study of ZD4054 in Metastatic Prostate Cancer
The Christie NHS Foundation Trust
Phase NA Unknown